Question 1

Does Neuberger Berman Group own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Neuberger Berman Group holds 156,523 shares of AXSM (Axsome Therapeutics), worth $38.3M.

Question 2

How many shares of AXSM does Neuberger Berman Group own?

Accepted Answer

As of its Q2 2026 13F, Neuberger Berman Group holds 156,523 shares of AXSM (Axsome Therapeutics).

Question 3

What is Neuberger Berman Group's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, Neuberger Berman Group's AXSM position is worth $38.3M.

Question 4

Is Neuberger Berman Group buying or selling AXSM?

Accepted Answer

In Q2 2026, Neuberger Berman Group increased its AXSM position by 95,764 shares (+157.6%).

Question 5

When did Neuberger Berman Group first buy AXSM?

Accepted Answer

Neuberger Berman Group first reported AXSM in its Q1 2019 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	156,523	+157.6%	$38.3M	0.0%	$244.77	47
2026-Q1	Decreased	60,759	-12.6%	$10.3M	0.0%	$169.02	0
2025-Q4	Decreased	69,483	-23.8%	$12.7M	0.0%	$182.64	0
2025-Q3	Increased	91,178	+29.1%	$11.1M	0.0%	$121.45	35
2025-Q2	New	70,632	—	$7.4M	0.0%	$104.39	38
2024-Q4	Exited	0	-100.0%	$0	0.0%	$84.61	0
2024-Q3	Increased	80,014	+7.0%	$7.2M	0.0%	$89.87	29